Our Medicines - Serving Patients
We are proud to offer innovative prescription and non-prescription medicines for a wide range of conditions.
The following are the products of Boehringer Ingelheim (Canada) Ltd./Ltée. The information contained in the links is intended for Canadian healthcare professionals and patients.
Products marked with an asterisk(*) denote that the current Product Monograph and Consumer Information posted here are in the process of being translated and will be posted upon availability. For the most current version, please refer to the English documents.
Our Products
| Brand Name | Product Monograph | Consumer Information |
| Aggrenox | Download | Download |
| Aptivus | Download | Download |
| Atrovent HFA | Download | Download |
| Basaglar | Download | Download |
| Combivent Respimat | Download | Download |
| Combivent UDV | Download | Download |
| Flomax CR | Download | Download |
| Giotrif | Download | Download |
| Glyxambi | Download | Download |
| Inspiolto Respimat | Download | Download |
| Jardiance | Download | Download |
| JentaDueto | Download | Download |
| Micardis | Download | Download |
| Micardis Plus | Download | Download |
| Mirapex | Download | Download |
| Mobicox | Download | Download |
| Ofev | Download | Download |
| Persantine | Download | Download |
| Pradaxa (New Name) | Download* | Download* |
| Praxbind | Download | Download |
| Spiriva | Download | Download |
| Spiriva Respimat | Download | Download |
| Striverdi Respimat | Download | Download |
| Synjardy | Download | Download |
| Trajenta | Download | Download |
| Twynsta | Download | Download |
| Viramune | Download | Download |
Medications Return Programs
For more information and to locate a safe disposal drop-off location near you, visit www.healthsteward.ca
Important information regarding Pradaxa® (dabigatran etexilate)
| November 2011 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
| December 2012 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
| March 2012 | |
| Dear Healthcare Professionnal Letter | View document |
| Public Communication | View document |
Important information regarding Ofev® (nintedanib)
| January 2018 | |
| Dear Healthcare Professionnal Letter | View document |